MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 26.88
-0.22 (-0.81%)
Jul 13, 2026, 5:35 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €965.1 million as of July 13, 2026. Its market cap has increased by 77.42% in one year.
Market Cap
965.10M
Enterprise Value
935.31M
Revenue
24.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
€26.88
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 965.10M, an increase of 560.55%. That is a compound annual growth rate of 27.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 965.10M | 15.69% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 10.59B |
| Nanobiotix | 1.80B |
| Inventiva | 881.33M |
| DBV Technologies | 843.95M |
| Genfit | 687.33M |
| Valneva SE | 413.24M |
| Valerio Therapeutics Société anonyme | 224.75M |
| Transgene | 207.33M |